{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T17:14:18Z","timestamp":1776878058882,"version":"3.51.2"},"reference-count":175,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["24K10410"],"award-info":[{"award-number":["24K10410"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The most important issues in acute myeloid leukemia are preventing relapse and treating relapse. Although the remission rate has improved to approximately 80%, the 5-year survival rate is only around 30%. The main reasons for this are the high relapse rate and the limited treatment options. In chronic myeloid leukemia patients, when a deep molecular response is achieved for a certain period of time through tyrosine kinase inhibitor treatment, about half of them will reach treatment-free remission, but relapse is still a problem. Therefore, potential therapeutic targets for myeloid leukemias are eagerly awaited. Autophagy suppresses the development of cancer by maintaining cellular homeostasis; however, it also promotes cancer progression by helping cancer cells survive under various metabolic stresses. In addition, autophagy is promoted or suppressed in cancer cells by various genetic mutations. Therefore, the development of therapies that target autophagy is also being actively researched in the field of leukemia. In this review, studies of the role of autophagy in hematopoiesis, leukemogenesis, and myeloid leukemias are presented, and the impact of autophagy regulation on leukemia treatment and the clinical trials of autophagy-related drugs to date is discussed.<\/jats:p>","DOI":"10.3390\/ijms252212219","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T04:15:49Z","timestamp":1731557749000},"page":"12219","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Current Understanding of the Role of Autophagy in the Treatment of Myeloid Leukemia"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7785-1362","authenticated-orcid":false,"given":"Yasushi","family":"Kubota","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Saga-Ken Medical Centre Koseikan, Saga 840-8571, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Kimura","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga 849-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: Renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1101\/gad.287524.116","article-title":"Recent insights into the function of autophagy in cancer","volume":"30","author":"Amaravadi","year":"2016","journal-title":"Genes Dev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nbt.2285","article-title":"Therapeutic targets in cancer cell metabolism and autophagy","volume":"30","author":"Cheong","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc3262","article-title":"Deconvoluting the context-dependent role for autophagy in cancer","volume":"12","author":"White","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.molcel.2010.09.023","article-title":"Autophagy and the integrated stress response","volume":"40","author":"Kroemer","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrm3028","article-title":"Mechanisms of mitophagy","volume":"12","author":"Youle","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1007\/s00277-024-05635-w","article-title":"Leukemia and mitophagy: A novel perspective for understanding oncogenesis and resistance","volume":"103","author":"Liu","year":"2024","journal-title":"Ann. Hematol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1534-5807(03)00296-X","article-title":"A unified nomenclature for yeast autophagy-related genes","volume":"5","author":"Klionsky","year":"2003","journal-title":"Dev. Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrm1660","article-title":"Autophagy in metazoans: Cell survival in the land of plenty","volume":"6","author":"Lum","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41580-020-0241-0","article-title":"Mechanisms governing autophagosome biogenesis","volume":"21","author":"Nakatogawa","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jb\/mvab017","article-title":"Structural catalog of core Atg proteins opens new era of autophagy research","volume":"169","author":"Matoba","year":"2021","journal-title":"J. Biochem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1083\/jcb.152.4.657","article-title":"Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells","volume":"152","author":"Mizushima","year":"2001","journal-title":"J. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/10408363.2015.1135103","article-title":"Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects","volume":"53","author":"Mukhopadhyay","year":"2016","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/45257","article-title":"Induction of autophagy and inhibition of tumorigenesis by beclin 1","volume":"402","author":"Liang","year":"1999","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"15077","DOI":"10.1073\/pnas.2436255100","article-title":"Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor","volume":"100","author":"Yue","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1172\/JCI20039","article-title":"Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene","volume":"112","author":"Qu","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.2696","article-title":"Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary","volume":"221","author":"Ahmed","year":"2010","journal-title":"J. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1101\/gad.2016211","article-title":"Autophagy-deficient mice develop multiple liver tumors","volume":"25","author":"Takamura","year":"2011","journal-title":"Genes Dev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1083\/jcb.201102031","article-title":"Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells","volume":"193","author":"Inami","year":"2011","journal-title":"J. Cell Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13046-020-01580-4","article-title":"ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia","volume":"39","author":"Hwang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41467-019-13923-7","article-title":"ULK1 phosphorylates Exo70 to suppress breast cancer metastasis","volume":"11","author":"Mao","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12935-019-1054-0","article-title":"Blocking AMPK\/ULK1-dependent autophagy promoted apoptosis and suppressed colon cancer growth","volume":"19","author":"Liu","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.freeradbiomed.2015.07.159","article-title":"Autophagy protein Ulk1 promotes mitochondrial apoptosis through reactive oxygen species","volume":"89","author":"Mukhopadhyay","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s43018-021-00208-6","article-title":"ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancer","volume":"2","author":"Deng","year":"2021","journal-title":"Nat. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Jimenez-Mora, E., Gallego, B., Diaz-Gago, S., Lasa, M., Baquero, P., and Chiloeches, A. (2021). (V600E)BRAF Inhibition Induces Cytoprotective Autophagy through AMPK in Thyroid Cancer Cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22116033"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1101\/gad.276428.115","article-title":"Distinct roles of autophagy-dependent and -independent functions of FIP200 revealed by generation and analysis of a mutant knock-in mouse model","volume":"30","author":"Chen","year":"2016","journal-title":"Genes Dev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature11910","article-title":"Autophagosomes form at ER-mitochondria contact sites","volume":"495","author":"Hamasaki","year":"2013","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.freeradbiomed.2017.01.007","article-title":"ATG14 facilitated lipophagy in cancer cells induce ER stress mediated mitoptosis through a ROS dependent pathway","volume":"104","author":"Mukhopadhyay","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1182\/blood-2010-06-288589","article-title":"FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells","volume":"116","author":"Liu","year":"2010","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1084\/jem.20101145","article-title":"The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance","volume":"208","author":"Mortensen","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.4110\/in.2019.19.e12","article-title":"The autophagy Protein Atg5 Plays a Crucial Role in the Maintenance and Reconstitution Ability of Hematopoietic Stem Cells","volume":"19","author":"Jung","year":"2019","journal-title":"Immune Netw."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Nomura, N., Ito, C., Ooshio, T., Tadokoro, Y., Kohno, S., Ueno, M., Kobayashi, M., Kasahara, A., Takase, Y., and Kurayoshi, K. (2021). Essential role of autophagy in protecting neonatal haematopoietic stem cells from oxidative stress in a p62-independent manner. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-81076-z"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.exphem.2014.11.002","article-title":"Autophagy regulates the cell cycle of murine HSPCs in a nutrient-dependent manner","volume":"43","author":"Cao","year":"2015","journal-title":"Exp. Hematol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.stem.2010.07.011","article-title":"The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche","volume":"7","author":"Simsek","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature11895","article-title":"FOXO3A directs a protective autophagy program in haematopoietic stem cells","volume":"494","author":"Warr","year":"2013","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1182\/blood-2014-03-562660","article-title":"Autophagy is required for stem cell mobilization by G-CSF","volume":"125","author":"Vu","year":"2015","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"15008","DOI":"10.1038\/cddiscovery.2015.8","article-title":"Autophagy limits proliferation and glycolytic metabolism in acute myeloid leukemia","volume":"1","author":"Watson","year":"2015","journal-title":"Cell Death Discov."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/stem.2347","article-title":"Autophagy Proteins ATG5 and ATG7 Are Essential for the Maintenance of Human CD34(+) Hematopoietic Stem-Progenitor Cells","volume":"34","author":"Folkerts","year":"2016","journal-title":"Stem Cells"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nature21388","article-title":"Autophagy maintains the metabolism and function of young and old stem cells","volume":"543","author":"Ho","year":"2017","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1038\/onc.2010.561","article-title":"Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis","volume":"30","author":"Altman","year":"2011","journal-title":"Oncogene"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e2361","DOI":"10.1038\/cddis.2016.264","article-title":"Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model","volume":"7","author":"Liu","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.molcel.2016.04.011","article-title":"U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3\u2032 End Formation","volume":"62","author":"Park","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1182\/blood-2015-12-684696","article-title":"Cytoprotective autophagy maintains leukemia-initiating cells in murine myeloid leukemia","volume":"128","author":"Sumitomo","year":"2016","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1242\/jcs.01287","article-title":"Alfy, a novel FYVE-domain-containing protein associated with protein granules and autophagic membranes","volume":"117","author":"Simonsen","year":"2004","journal-title":"J. Cell Sci."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Schlafli, A.M., Isakson, P., Garattini, E., Simonsen, A., and Tschan, M.P. (2017). The autophagy scaffold protein ALFY is critical for the granulocytic differentiation of AML cells. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-12734-4"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1482795","DOI":"10.1155\/2018\/1482795","article-title":"Low Autophagy (ATG) Gene Expression Is Associated with an Immature AML Blast Cell Phenotype and Can Be Restored during AML Differentiation Therapy","volume":"2018","author":"Jin","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Rothe, K., Porter, V., and Jiang, X. (2019). Current Outlook on Autophagy in Human Leukemia: Foe in Cancer Stem Cells and Drug Resistance, Friend in New Therapeutic Interventions. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030461"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1080\/15548627.2015.1067362","article-title":"Cross-cancer profiling of molecular alterations within the human autophagy interaction network","volume":"11","author":"Lebovitz","year":"2015","journal-title":"Autophagy"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"74917","DOI":"10.18632\/oncotarget.12493","article-title":"Autophagy mediates proteolysis of NPM1 and HEXIM1 and sensitivity to BET inhibition in AML cells","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.7150\/thno.19439","article-title":"NPM1 Mutant Mediated PML Delocalization and Stabilization Enhances Autophagy and Cell Survival in Leukemic Cells","volume":"7","author":"Zou","year":"2017","journal-title":"Theranostics"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"882","DOI":"10.7150\/ijbs.30290","article-title":"Glycolytic Enzyme PKM2 Mediates Autophagic Activation to Promote Cell Survival in NPM1-Mutated Leukemia","volume":"15","author":"Wang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e21192","DOI":"10.1096\/fj.201903183RRR","article-title":"NPM1 mutant maintains ULK1 protein stability via TRAF6-dependent ubiquitination to promote autophagic cell survival in leukemia","volume":"35","author":"Tang","year":"2021","journal-title":"FASEB J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.canlet.2019.03.055","article-title":"H22954, a novel long non-coding RNA down-regulated in AML, inhibits cancer growth in a BCL-2-dependent mechanism","volume":"454","author":"Qi","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13148-018-0486-z","article-title":"H19 overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia","volume":"10","author":"Zhang","year":"2018","journal-title":"Clin. Epigenet."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13046-021-02122-2","article-title":"Mutant NPM1-regulated lncRNA HOTAIRM1 promotes leukemia cell autophagy and proliferation by targeting EGR1 and ULK3","volume":"40","author":"Jing","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1080\/15548627.2020.1713646","article-title":"The bifunctional role of TP53INP2 in transcription and autophagy","volume":"16","author":"Xu","year":"2020","journal-title":"Autophagy"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Huang, J., Sun, M., Tao, Y., Ren, J., Peng, M., Jing, Y., Xiao, Q., Yang, J., Lin, C., and Lei, L. (2023). Cytoplasmic Expression of TP53INP2 Modulated by Demethylase FTO and Mutant NPM1 Promotes Autophagy in Leukemia Cells. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021624"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"113484","DOI":"10.1016\/j.celrep.2023.113484","article-title":"An atypical GABARAP binding module drives the pro-autophagic potential of the AML-associated NPM1c variant","volume":"42","author":"Mende","year":"2023","journal-title":"Cell Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/blood-2002-02-0492","article-title":"The roles of FLT3 in hematopoiesis and leukemia","volume":"100","author":"Gilliland","year":"2002","journal-title":"Blood"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/bmt.2015.170","article-title":"FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML","volume":"51","author":"Song","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1182\/blood-2016-04-708750","article-title":"Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML","volume":"128","author":"Dany","year":"2016","journal-title":"Blood"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/s41375-018-0102-4","article-title":"RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia","volume":"32","author":"Rudat","year":"2018","journal-title":"Leukemia"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1038\/s41375-022-01678-y","article-title":"Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia","volume":"36","author":"Koschade","year":"2022","journal-title":"Leukemia"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1182\/blood.V128.22.525.525","article-title":"Development of ROC-325: A Novel Small Molecule Inhibitor of Autophagy with Promising Anti-Leukemic Activity","volume":"128","author":"Nawrocki","year":"2016","journal-title":"Blood"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.1073\/pnas.1118193109","article-title":"Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency","volume":"109","author":"McAfee","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3324\/haematol.2022.280884","article-title":"Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy","volume":"108","author":"Zhang","year":"2023","journal-title":"Haematologica"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.1182\/blood-2022-167759","article-title":"A Phase 1a\/b Dose Escalation Study of the FLT3\/BTK Inhibitor Luxeptinib (CG-806) in Patients with Relapsed or Refractory Acute Myeloid Leukemia","volume":"140","author":"Goldberg","year":"2022","journal-title":"Blood"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","year":"2012","journal-title":"Nature"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/leu.2008.143","article-title":"Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype","volume":"22","author":"Haferlach","year":"2008","journal-title":"Leukemia"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e2927","DOI":"10.1038\/cddis.2017.317","article-title":"Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia","volume":"8","author":"Folkerts","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/humu.10190","article-title":"TP53 in hematological cancer: Low incidence of mutations with significant clinical relevance","volume":"21","author":"Peller","year":"2003","journal-title":"Hum. Mutat."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJMoa1611604","article-title":"Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation","volume":"376","author":"Lindsley","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2011-08-375758","article-title":"TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome","volume":"119","author":"Rucker","year":"2012","journal-title":"Blood"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Allende-Vega, N., and Villalba, M. (2019). Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cells. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-42220-y"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Janovska, P., Normant, E., Miskin, H., and Bryja, V. (2020). Targeting Casein Kinase 1 (CK1) in Hematological Cancers. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239026"},{"key":"ref_76","first-page":"1895","article-title":"Casein kinase 1alpha inhibits p53 downstream of MDM2-mediated autophagy and apoptosis in acute myeloid leukemia","volume":"44","author":"Xu","year":"2020","journal-title":"Oncol. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Xu, Y., Tran, L., Tang, J., Nguyen, V., Sewell, E., Xiao, J., Hino, C., Wasnik, S., Francis-Boyle, O.L., and Zhang, K.K. (2022). FBP1-Altered Carbohydrate Metabolism Reduces Leukemic Viability through Activating P53 and Modulating the Mitochondrial Quality Control System In Vitro. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911387"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1111\/jcmm.17765","article-title":"Combined inhibition of XIAP and autophagy induces apoptosis and differentiation in acute myeloid leukaemia","volume":"27","author":"Huang","year":"2023","journal-title":"J. Cell Mol. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/0008-5472.CAN-13-3455","article-title":"Tropomodulin 1 expression driven by NF-kappaB enhances breast cancer growth","volume":"75","author":"Koshikawa","year":"2015","journal-title":"Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1182\/blood-2012-01-405555","article-title":"Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma","volume":"120","author":"Agnelli","year":"2012","journal-title":"Blood"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.arcmed.2016.12.005","article-title":"Gene Expression Profiling of Acute Lymphoblastic Leukemia in Children with Very Early Relapse","volume":"47","year":"2016","journal-title":"Arch. Med. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"107327","DOI":"10.1016\/j.phrs.2024.107327","article-title":"Silencing of tropomodulin 1 inhibits acute myeloid leukemia cell proliferation and tumor growth by elevating karyopherin alpha 2-mediated autophagy","volume":"207","author":"Xia","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3390\/jcm4040504","article-title":"The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia Therapy","volume":"4","author":"Gocek","year":"2015","journal-title":"J. Clin. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2017.01.007","article-title":"Application of vitamin D and vitamin D analogs in acute myelogenous leukemia","volume":"50","author":"Cao","year":"2017","journal-title":"Exp. Hematol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Medrano, M., Carrillo-Cruz, E., Montero, I., and Perez-Simon, J.A. (2018). Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092663"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.celrep.2016.09.012","article-title":"Developmental Vitamin D Availability Impacts Hematopoietic Stem Cell Production","volume":"17","author":"Cortes","year":"2016","journal-title":"Cell Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1007\/s11010-021-04208-z","article-title":"Vitamin D promotes autophagy in AML cells by inhibiting miR-17-5p-induced Beclin-1 overexpression","volume":"476","author":"Wang","year":"2021","journal-title":"Mol. Cell Biochem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood-2010-01-261040","article-title":"Autophagy contributes to therapy-induced degradation of the PML\/RARA oncoprotein","volume":"116","author":"Isakson","year":"2010","journal-title":"Blood"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.exphem.2015.04.012","article-title":"Induction of autophagy is a key component of all-trans-retinoic acid-induced differentiation in leukemia cells and a potential target for pharmacologic modulation","volume":"43","author":"Orfali","year":"2015","journal-title":"Exp. Hematol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/s41467-017-01948-9","article-title":"Dendrogenin A drives LXR to trigger lethal autophagy in cancers","volume":"8","author":"Segala","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Serhan, N., Mouchel, P.L., Medina, P., Segala, G., Mougel, A., Saland, E., Rives, A., Lamaziere, A., Despres, G., and Sarry, J.E. (2020). Dendrogenin A synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo. Cancers, 12.","DOI":"10.3390\/cancers12071725"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Mouchel, P.L., Serhan, N., Betous, R., Farge, T., Saland, E., De Medina, P., Hoffmann, J.S., Sarry, J.E., Poirot, M., and Silvente-Poirot, S. (2020). Dendrogenin A Enhances Anti-Leukemic Effect of Anthracycline in Acute Myeloid Leukemia. Cancers, 12.","DOI":"10.3390\/cancers12102933"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.leukres.2015.09.016","article-title":"Metformin synergistically sensitizes FLT3-ITD-positive acute myeloid leukemia to sorafenib by promoting mTOR-mediated apoptosis and autophagy","volume":"39","author":"Wang","year":"2015","journal-title":"Leuk. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"101645","DOI":"10.1016\/j.xcrm.2024.101645","article-title":"Metformin synergizes with gilteritinib in treating FLT3-mutated leukemia via targeting PLK1 signaling","volume":"5","author":"Chen","year":"2024","journal-title":"Cell Rep. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"9429","DOI":"10.18632\/oncotarget.6990","article-title":"A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells","volume":"7","author":"Fu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3324\/haematol.2018.199661","article-title":"The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells","volume":"104","author":"Spinello","year":"2019","journal-title":"Haematologica"},{"key":"ref_97","first-page":"1244","article-title":"Quercetin induces autophagy-associated death in HL-60 cells through CaMKK\u03b2\/AMPK\/mTOR signal pathway","volume":"54","author":"Xiao","year":"2022","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Jang, J.Y., Im, E., and Kim, N.D. (2022). Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213689"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Fan, Y., Chiu, J.F., Liu, J., Deng, Y., Xu, C., Zhang, J., and Li, G. (2018). Resveratrol induces autophagy-dependent apoptosis in HL-60 cells. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4504-5"},{"key":"ref_100","first-page":"825","article-title":"The wine polyphenol resveratrol modulates autophagy and induces apoptosis in MOLT-4 and HL-60 human leukemia cells","volume":"70","author":"Wozniak","year":"2019","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Tapia, M., Hernando, C., Mart\u00ednez, M.T., Burgu\u00e9s, O., Tebar-S\u00e1nchez, C., Lameirinhas, A., \u00c1greda-Roca, A., Torres-Ruiz, S., Garrido-Cano, I., and Lluch, A. (2023). Clinical Impact of New Treatment Strategies for HER2-Positive Metastatic Breast Cancer Patients with Resistance to Classical Anti-HER Therapies. Cancers, 15.","DOI":"10.3390\/cancers15184522"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/ddr.21983","article-title":"Neratinib inhibits proliferation and promotes apoptosis of acute myeloid leukemia cells by activating autophagy-dependent ferroptosis","volume":"83","author":"Ma","year":"2022","journal-title":"Drug Dev. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Berndt, C., Alborzinia, H., Amen, V.S., Ayton, S., Barayeu, U., Bartelt, A., Bayir, H., Bebber, C.M., Birsoy, K., and B\u00f6ttcher, J.P. (2024). Ferroptosis in health and disease. Redox Biol., 75.","DOI":"10.1016\/j.redox.2024.103211"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2017.01.016","article-title":"Autophagy contributes to 4-Amino-2-Trifluoromethyl-Phenyl Retinate-induced differentiation in human acute promyelocytic leukemia NB4 cells","volume":"319","author":"Li","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.intimp.2018.10.041","article-title":"A novel all-trans retinoic acid derivative inhibits proliferation and induces apoptosis of myelodysplastic syndromes cell line SKM-1 cells via up-regulating p53","volume":"65","author":"Du","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"144889","DOI":"10.1016\/j.gene.2020.144889","article-title":"Targeting ferroptosis contributes to ATPR-induced AML differentiation via ROS-autophagy-lysosomal pathway","volume":"755","author":"Du","year":"2020","journal-title":"Gene"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.freeradbiomed.2018.12.011","article-title":"DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin","volume":"131","author":"Du","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature13148","article-title":"Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy","volume":"509","author":"Mancias","year":"2014","journal-title":"Nature"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"eadk1731","DOI":"10.1126\/scitranslmed.adk1731","article-title":"Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models","volume":"16","author":"Larrue","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1021\/acscentsci.0c01592","article-title":"Inhibiting Ferroptosis through Disrupting the NCOA4-FTH1 Interaction: A New Mechanism of Action","volume":"7","author":"Fang","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Kubota, Y., Hoshiko, T., Higashi, T., Motoyama, K., Okada, S., and Kimura, S. (2023). Folate-Appended Hydroxypropyl-beta-Cyclodextrin Induces Autophagic Cell Death in Acute Myeloid Leukemia Cells. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242316720"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.biopha.2015.05.012","article-title":"Induction of cytosine arabinoside-resistant human myeloid leukemia cell death through autophagy regulation by hydroxychloroquine","volume":"73","author":"Kim","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/15548627.2017.1287652","article-title":"Autophagy is dispensable for Kmt2a\/Mll-Mllt3\/Af9 AML maintenance and anti-leukemic effect of chloroquine","volume":"13","author":"Chen","year":"2017","journal-title":"Autophagy"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Gr\u00f8nnings\u00e6ter, I.S., Reikvam, H., Aaseb\u00f8, E., Bartaula-Brevik, S., Hernandez-Valladares, M., Selheim, F., Berven, F.S., Tvedt, T.H., Bruserud, \u00d8., and Hatfield, K.J. (2021). Effects of the Autophagy-Inhibiting Agent Chloroquine on Acute Myeloid Leukemia Cells; Characterization of Patient Heterogeneity. J. Pers. Med., 11.","DOI":"10.3390\/jpm11080779"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Visser, N., Lourens, H.J., Huls, G., Bremer, E., and Wiersma, V.R. (2021). Inhibition of Autophagy Does Not Re-Sensitize Acute Myeloid Leukemia Cells Resistant to Cytarabine. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052337"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1080\/15548627.2015.1066957","article-title":"Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A\/SERCA-dependent autophagosome-lysosome fusion","volume":"11","author":"Mauvezin","year":"2015","journal-title":"Autophagy"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1182\/bloodadvances.2020002666","article-title":"Inhibiting autophagy targets human leukemic stem cells and hypoxic AML blasts by disrupting mitochondrial homeostasis","volume":"5","author":"Dykstra","year":"2021","journal-title":"Blood Adv."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/nchembio.1681","article-title":"A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy","volume":"10","author":"Ronan","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/onc.2017.376","article-title":"Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia","volume":"37","author":"Heydt","year":"2018","journal-title":"Oncogene"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Dupont, M., Huart, M., Lauvinerie, C., Bidet, A., Guitart, A.V., Villacreces, A., Vigon, I., Desplat, V., El Habhab, A., and Pigneux, A. (2022). Autophagy Targeting and Hematological Mobilization in FLT3-ITD Acute Myeloid Leukemia Decrease Repopulating Capacity and Relapse by Inducing Apoptosis of Committed Leukemic Cells. Cancers, 14.","DOI":"10.3390\/cancers14020453"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/BJ20140889","article-title":"Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase","volume":"463","author":"Bago","year":"2014","journal-title":"Biochem. J."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41389-020-00278-8","article-title":"Antileukemic activity of the VPS34-IN1 inhibitor in acute myeloid leukemia","volume":"9","author":"Meunier","year":"2020","journal-title":"Oncogenesis"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"24131","DOI":"10.1074\/jbc.M702824200","article-title":"p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy","volume":"282","author":"Pankiv","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/leu.2015.229","article-title":"Blocking the ZZ domain of sequestosome1\/p62 suppresses myeloma growth and osteoclast formation in vitro and induces dramatic bone formation in myeloma-bearing bones in vivo","volume":"30","author":"Teramachi","year":"2016","journal-title":"Leukemia"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.canlet.2021.04.003","article-title":"A mitophagy inhibitor targeting p62 attenuates the leukemia-initiation potential of acute myeloid leukemia cells","volume":"510","author":"Li","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41419-017-0170-9","article-title":"Synergistic effect of a novel autophagy inhibitor and Quizartinib enhances cancer cell death","volume":"9","author":"Ouchida","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1158\/2767-9764.CRC-23-0507","article-title":"Autophagy Inhibition-induced Cytosolic DNA Sensing Combined with Differentiation Therapy Induces Irreversible Myeloid Differentiation in Leukemia Cells","volume":"4","author":"Baba","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejps.2019.04.011","article-title":"Autophagy as a molecular target for cancer treatment","volume":"134","author":"Kocaturk","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s12185-021-03127-5","article-title":"Current status and novel strategy of CML","volume":"113","author":"Morita","year":"2021","journal-title":"Int. J. Hematol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: The prospective, multicentre Stop Imatinib (STIM) trial","volume":"11","author":"Mahon","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.1016\/S2352-3026(15)00196-9","article-title":"Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): A multicentre phase 2 trial","volume":"2","author":"Imagawa","year":"2015","journal-title":"Lancet Haematol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10147-018-1368-2","article-title":"Feasibility of the imatinib stop study in the Japanese clinical setting: Delightedly overcome CML expert stop TKI trial (DOMEST Trial)","volume":"24","author":"Fujisawa","year":"2019","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12185-017-2334-x","article-title":"Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: The JALSG-STIM213 study","volume":"107","author":"Takahashi","year":"2018","journal-title":"Int. J. Hematol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/M17-1094","article-title":"Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study","volume":"168","author":"Mahon","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Bourne, G., Bhatia, R., and Jamy, O. (2024). Treatment-Free Remission in Chronic Myeloid Leukemia. J. Clin. Med., 13.","DOI":"10.3390\/jcm13092567"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","article-title":"The chronic myeloid leukemia stem cell: Stemming the tide of persistence","volume":"129","author":"Holyoake","year":"2017","journal-title":"Blood"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","article-title":"Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia","volume":"94","author":"Holyoake","year":"1999","journal-title":"Blood"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1182\/blood-2013-07-516807","article-title":"The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem\/progenitor cells","volume":"123","author":"Rothe","year":"2014","journal-title":"Blood"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1080\/15548627.2016.1162359","article-title":"ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells","volume":"12","author":"Karvela","year":"2016","journal-title":"Autophagy"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI35660","article-title":"Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells","volume":"119","author":"Bellodi","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ajh.21914","article-title":"Autophagy induction by Bcr-Abl-expressing cells facilitates their recovery from a targeted or nontargeted treatment","volume":"86","author":"Crowley","year":"2011","journal-title":"Am. J. Hematol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/cdd.2008.107","article-title":"The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias","volume":"15","author":"Kamitsuji","year":"2008","journal-title":"Cell Death Differ."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12185-016-2137-5","article-title":"Dasatinib induces autophagy in mice with Bcr-Abl-positive leukemia","volume":"105","author":"Morita","year":"2017","journal-title":"Int. J. Hematol."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Han, W., Sun, J., Feng, L., Wang, K., Li, D., Pan, Q., Chen, Y., Jin, W., Wang, X., and Pan, H. (2011). Autophagy inhibition enhances daunorubicin-induced apoptosis in K562 cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028491"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e29911","DOI":"10.4161\/mco.29911","article-title":"Chloroquine and hydroxychloroquine for cancer therapy","volume":"1","author":"Manic","year":"2014","journal-title":"Mol. Cell Oncol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/s41375-019-0700-9","article-title":"A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease","volume":"34","author":"Horne","year":"2020","journal-title":"Leukemia"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41375-018-0252-4","article-title":"Targeting quiescent leukemic stem cells using second generation autophagy inhibitors","volume":"33","author":"Baquero","year":"2019","journal-title":"Leukemia"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nrd3531","article-title":"Rapamycin passes the torch: A new generation of mTOR inhibitors","volume":"10","author":"Benjamin","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/jnci\/djx236","article-title":"Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition","volume":"110","author":"Mitchell","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cell.2006.03.035","article-title":"A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling","volume":"125","author":"Knight","year":"2006","journal-title":"Cell"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-08-0017","article-title":"Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity","volume":"7","author":"Maira","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Lang, F., Wunderle, L., Badura, S., Schleyer, E., Br\u00fcggemann, M., Serve, H., Schnittger, S., G\u00f6kbuget, N., Pfeifer, H., and Wagner, S. (2020). A phase I study of a dual PI3-kinase\/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemia. BMC Pharmacol. Toxicol., 21.","DOI":"10.1186\/s40360-020-00446-x"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood-2006-10-050260","article-title":"Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance","volume":"110","author":"Carew","year":"2007","journal-title":"Blood"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1007\/s13577-023-00919-1","article-title":"HDAC inhibitor chidamide overcomes drug resistance in chronic myeloid leukemia with the T315i mutation through the Akt-autophagy pathway","volume":"36","author":"Yin","year":"2023","journal-title":"Human. Cell"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Hoshiko, T., Kubota, Y., Onodera, R., Higashi, T., Yokoo, M., Motoyama, K., and Kimura, S. (2021). Folic Acid-Appended Hydroxypropyl-beta-Cyclodextrin Exhibits Potent Antitumor Activity in Chronic Myeloid Leukemia Cells via Autophagic Cell Death. Cancers, 13.","DOI":"10.3390\/cancers13215413"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Yokoo, M., Kubota, Y., Motoyama, K., Higashi, T., Taniyoshi, M., Tokumaru, H., Nishiyama, R., Tabe, Y., Mochinaga, S., and Sato, A. (2015). 2-Hydroxypropyl-beta-Cyclodextrin Acts as a Novel Anticancer Agent. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0141946"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.leukres.2013.09.003","article-title":"A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia","volume":"37","author":"Howard","year":"2013","journal-title":"Leuk. Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1200\/JCO.2012.45.2177","article-title":"Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502","volume":"31","author":"Attar","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/cam4.2883","article-title":"A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide","volume":"9","author":"Kulkarni","year":"2020","journal-title":"Cancer Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/pbc.25117","article-title":"A Phase 2 study of bortezomib combined with either idarubicin\/cytarabine or cytarabine\/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: A report from the Children\u2019s Oncology Group","volume":"61","author":"Horton","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10637-018-0585-x","article-title":"Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibition","volume":"36","author":"Kasner","year":"2018","journal-title":"Invest. New Drugs"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.2004.07.048","article-title":"Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: A phase III trial (E2995)","volume":"22","author":"Greenberg","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2141.2011.08940.x","article-title":"Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: Results of a phase II GIMEMA study (AML-1107)","volume":"156","author":"Amadori","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/leu.2013.17","article-title":"A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse","volume":"27","author":"Park","year":"2013","journal-title":"Leukemia"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/10428194.2017.1334122","article-title":"Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia","volume":"59","author":"Tiong","year":"2018","journal-title":"Leuk. Lymphoma"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00109-011-0785-8","article-title":"Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo","volume":"89","author":"Zachar","year":"2011","journal-title":"J. Mol. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2049-3002-2-4","article-title":"A strategically designed small molecule attacks alpha-ketoglutarate dehydrogenase in tumor cells through a redox process","volume":"2","author":"Stuart","year":"2014","journal-title":"Cancer Metab."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s41467-022-29039-4","article-title":"Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia","volume":"13","author":"Anderson","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1158\/1078-0432.CCR-17-2282","article-title":"A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia","volume":"24","author":"Pardee","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"100009","DOI":"10.1016\/j.bneo.2024.100009","article-title":"Devimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: Results of the ARMADA trial","volume":"1","author":"Pardee","year":"2024","journal-title":"Blood Neoplasia"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Huang, H., Wenbing, Y., Dong, A., He, Z., Yao, R., and Guo, W. (2019). Chidamide Enhances the Cytotoxicity of Cytarabine and Sorafenib in Acute Myeloid Leukemia Cells by Modulating H3K9me3 and Autophagy Levels. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.01276"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13148-020-00923-4","article-title":"Chidamide, decitabine, cytarabine, aclarubicin, and granulocyte colony-stimulating factor (CDCAG) in patients with relapsed\/refractory acute myeloid leukemia: A single-arm, phase 1\/2 study","volume":"12","author":"Wang","year":"2020","journal-title":"Clin. Epigenet."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Wojcicki, A.V., Kadapakkam, M., Frymoyer, A., Lacayo, N., Chae, H.D., and Sakamoto, K.M. (2020). Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit?. Cancers, 12.","DOI":"10.3390\/cancers12020441"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/12219\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:32:11Z","timestamp":1760113931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/12219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":175,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["ijms252212219"],"URL":"https:\/\/doi.org\/10.3390\/ijms252212219","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]}}}